The adverse health effects resulting from exposure to contaminated soil on internally displaced populations in Mitrovica, Kosovo can be determined by how the potentially harmful elements are bound in the soils. Certainly this was the case for Pb, present at concentrations ranging from 624 to 46,900 mg/kg, and at bioaccessibilities ranging <5% to nearly 90%. To assess why the soil Pb might differ so markedly in terms of its bioaccessibility, computer controlled scanning electron microscopy (CCSEM) was employed to determine how the Pb was associated with other elements at the individual particle (IP) level in soils from the area. It was found that the Pb-bearing particle types were, for the most part, different in each sample. We consider these differences as the main control on Pb bioaccessibility in these soils. Pb solubility at the IP level was evaluated by examining Pb-particles from these soils in the electron microscope before and after successive immersions in a simulated gastric fluid. This analysis (differential IP analysis) confirmed the CCSEM characterization that Pb associated with other higher atomic number elements (Fe, Zn, Cu and Ni) was less soluble than when it was present as isolated phases (e.g., as carbonate) or when it was bound with lower atomic number elements (Na, Al, Si, K, Ca). The heterogeneity in solubility and composition of the Pb-particles suggested that the Pb originated from a range of different anthropogenic activities. The nature of these different anthropogenic activities created the wide differences in Pb-bioaccessibilty by producing Pb bound in many different forms in the soil particles. This type of Pb-particle characterization highlights the role CCSEM analysis, and IP acid extraction, can play in providing supporting evidence alongside bioaccessibility data for applications in human health risk assessment and management of contaminated soil.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.envpol.2017.03.050 | DOI Listing |
Background/aims: Certain sociodemographic groups are routinely underrepresented in clinical trials, limiting generalisability. Here, we describe the extent to which enriched enrolment approaches yielded a diverse trial population enriched for older age in a randomised controlled trial of a blood-based multi-cancer early detection test (NCT05611632).
Methods: Participants aged 50-77 years were recruited from eight Cancer Alliance regions in England.
Dev Med Child Neurol
January 2025
Cerebral Palsy Alliance Research Institute, Specialty of Child and Adolescent Health, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Aim: To describe research priority-setting activities for cerebral palsy (CP) that have been conducted worldwide involving people with lived experience, focusing on participant characteristics, methods employed, identified research priorities, and collaboration as research partners.
Method: The JBI scoping review approach was followed. Six electronic databases and grey literature were searched for all publications up to February 2024.
Viruses
December 2024
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., Beijing 100176, China.
Human respiratory syncytial virus (RSV) remains a significant global health threat, particularly for vulnerable populations. Despite extensive research, effective antiviral therapies are still limited. To address this urgent need, we present AVP-GPT2, a deep-learning model that significantly outperforms its predecessor, AVP-GPT, in designing and screening antiviral peptides.
View Article and Find Full Text PDFPharmaceutics
January 2025
Innovation and Medical Science, SIFI S.p.A., 95025 Aci Sant'Antonio, Italy.
Retinal ganglion cell (RGC) protection represents an unmet need in glaucoma. This study assessed the neuroprotective, antioxidant, and anti-inflammatory effect of a new nutraceutical formulation named Epicolin, based on citicoline, homotaurine, epigallocatechin-3-gallate, forskolin, and vitamins, through in vitro and in vivo studies. The neuroprotective effect of Epicolin or its single components, and Epicolin compared to an untreated control and two marketed formulations [Formulation G (FG) and N (FN)], was evaluated in neuroblastoma cells (SH-SY5Y) challenged with staurosporine.
View Article and Find Full Text PDFPharmaceutics
December 2024
Department of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia.
Background/objectives: Selective laser sintering (SLS) is one of the most promising 3D printing techniques for pharmaceutical applications as it offers numerous advantages, such as suitability to work with already approved pharmaceutical excipients, the elimination of solvents, and the ability to produce fast-dissolving, porous dosage forms with high drug loading. When the powder mixture is exposed to elevated temperatures during SLS printing, the active ingredients can be converted from the crystalline to the amorphous state, which can be used as a strategy to improve the dissolution rate and bioavailability of poorly soluble drugs. This study investigates the potential application of SLS 3D printing for the fabrication of tablets containing the poorly soluble drug carvedilol with the aim of improving the dissolution rate of the drug by forming an amorphous form through the printing process.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!